• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机临床试验中的患者报告结局:ISOQOL 报告标准的制定。

Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.

机构信息

Queen's University, Kingston, ON, Canada.

出版信息

Qual Life Res. 2013 Aug;22(6):1161-75. doi: 10.1007/s11136-012-0252-1. Epub 2012 Sep 18.

DOI:10.1007/s11136-012-0252-1
PMID:22987144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3731511/
Abstract

PURPOSE

To develop expert consensus on a suite of reporting standards for HRQL outcomes of RCTs.

METHODS

A Task Force of The International Society of Quality of Life Research (ISOQOL) undertook a systematic review of the literature to identify candidate reporting standards for HRQL in RCTs. Subsequently, a web-based survey was circulated to the ISOQOL membership. Respondents were asked to rate candidate standards on a 4-point Likert scale based on their perceived value in reporting studies in which HRQL was a study outcome (primary or secondary). Results were synthesized into draft reporting guidelines, which were further reviewed by the membership to inform the final guidance.

RESULTS

Forty-six existing candidate standards for reporting HRQL results in RCTs were synthesized to produce a 40 item survey that was completed electronically by 161 respondents. The majority of respondents rated all 40 items to be either 'essential' or 'desirable' when HRQL was a primary RCT outcome. Ratings changed when HRQL was a secondary study outcome. Feedback on the survey findings resulted in the Task Force generalizing the guidance to include patient-reported outcomes (PROs). The final guidance, which recommends standards for use in reporting PROs generally, and more specifically, for PROs identified as primary study outcomes, was approved by the ISOQOL Board of Directors.

CONCLUSIONS

ISOQOL has developed a suite of recommended standards for reporting PRO results of RCTs. Improved reporting of PROs will enable accurate interpretation of evidence to inform patient choice, aid clinical decision making, and inform health policy.

摘要

目的

就 RCT 中健康相关生活质量(HRQL)结局的报告标准制定专家共识。

方法

国际生活质量研究学会(ISOQOL)的一个工作组对文献进行了系统回顾,以确定 RCT 中 HRQL 报告的候选标准。随后,进行了一项基于网络的 ISOQOL 成员调查。调查对象根据报告将 HRQL 作为主要或次要研究结局的研究时的感知价值,对候选标准进行 4 分李克特量表评分。结果被综合成报告指南草案,进一步由成员审查,为最终指导提供信息。

结果

综合了 46 项现有的 RCT 中报告 HRQL 结果的候选标准,产生了一个包含 40 个项目的调查,由 161 名受访者通过电子方式完成。当 HRQL 是主要 RCT 结局时,大多数受访者将所有 40 个项目的评分均评为“必要”或“理想”。当 HRQL 是次要研究结局时,评分会发生变化。对调查结果的反馈导致工作组将指导方针推广到包括患者报告结局(PRO)。最终的指导方针建议了一般报告 PRO 的标准,更具体地说,还建议了作为主要研究结局的 PRO 的标准,该指导方针得到了 ISOQOL 董事会的批准。

结论

ISOQOL 已经制定了一套用于报告 RCT 中 PRO 结果的推荐标准。改善 PRO 的报告将使证据能够更准确地解释,以告知患者选择、帮助临床决策并为卫生政策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/3731511/4449c84aee50/11136_2012_252_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/3731511/4449c84aee50/11136_2012_252_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/3731511/4449c84aee50/11136_2012_252_Fig1_HTML.jpg

相似文献

1
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.随机临床试验中的患者报告结局:ISOQOL 报告标准的制定。
Qual Life Res. 2013 Aug;22(6):1161-75. doi: 10.1007/s11136-012-0252-1. Epub 2012 Sep 18.
2
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准(CONSORT)以及医学期刊上发表的随机对照试验(RCT)的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
3
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
4
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.
5
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD001431. doi: 10.1002/14651858.CD001431.pub3.
10
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.

引用本文的文献

1
Quality of Life in Rectal Cancer Treatments: An Updated Systematic Review of Randomized Controlled Trials (2013-2023).直肠癌治疗中的生活质量:对随机对照试验的最新系统评价(2013 - 2023年)
Cancers (Basel). 2025 Jul 11;17(14):2310. doi: 10.3390/cancers17142310.
2
Health-related quality of life in patients undergoing laparoscopic versus open hemihepatectomy: a secondary analysis of the ORANGE II PLUS randomised controlled, phase 3, superiority trial.接受腹腔镜与开放性半肝切除术患者的健康相关生活质量:ORANGE II PLUS随机对照3期优效性试验的二次分析
Lancet Reg Health Eur. 2025 May 19;54:101311. doi: 10.1016/j.lanepe.2025.101311. eCollection 2025 Jul.
3

本文引用的文献

1
How to use the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) in orthodontic research.如何在正畸研究中使用标准议定书条目:干预试验建议 (SPIRIT)。
Dental Press J Orthod. 2022 Jul 4;27(3):e2220290. doi: 10.1590/2177-6709.27.3.e2220290.oar. eCollection 2022.
2
A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials.知识转化的挑战:癌症临床试验中生活质量数据的临床应用。
Qual Life Res. 2011 Sep;20(7):979-85. doi: 10.1007/s11136-011-9848-0. Epub 2011 Jan 29.
3
Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).
Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013-2024).
患者报告的美国食品药品监督管理局(FDA)批准的用于全身性风湿性疾病的药物的疗效(2013 - 2024年)
Health Qual Life Outcomes. 2025 May 28;23(1):52. doi: 10.1186/s12955-025-02386-8.
4
Systematic evaluation of patient-reported outcomes in clinical trials of digital health in cardiovascular diseases.心血管疾病数字健康临床试验中患者报告结局的系统评价。
NPJ Digit Med. 2025 May 2;8(1):238. doi: 10.1038/s41746-025-01637-8.
5
Health-related quality-of-life outcomes in CNS WHO grade 2 and 3 meningioma: a systematic review.中枢神经系统世界卫生组织2级和3级脑膜瘤的健康相关生活质量结果:一项系统综述。
Neurosurg Rev. 2025 Feb 27;48(1):268. doi: 10.1007/s10143-025-03420-5.
6
Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group.涉及神经肿瘤护理人员的随机对照试验报告标准:RANO-Cares工作组的系统评价报告
Neurooncol Pract. 2024 Sep 20;12(1):19-33. doi: 10.1093/nop/npae086. eCollection 2025 Feb.
7
Investigating item response theory model performance in the context of evaluating clinical outcome assessments in clinical trials.在评估临床试验中临床结局评估的背景下研究项目反应理论模型的性能。
Qual Life Res. 2025 Apr;34(4):1125-1136. doi: 10.1007/s11136-024-03873-z. Epub 2024 Dec 12.
8
Assessing the completeness of patient-reported outcomes reporting in congestive heart failure clinical trials.评估充血性心力衰竭临床试验中患者报告结局报告的完整性。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241303724. doi: 10.1177/17539447241303724.
9
Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic review.转移性激素敏感性前列腺癌随机对照试验中与健康相关的生活质量结果:一项系统评价
EClinicalMedicine. 2024 Nov 13;78:102914. doi: 10.1016/j.eclinm.2024.102914. eCollection 2024 Dec.
10
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 版。
Qual Life Res. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9.
乳腺癌随机临床试验中的生活质量测量:更新的系统评价(2001-2009)。
J Natl Cancer Inst. 2011 Feb 2;103(3):178-231. doi: 10.1093/jnci/djq508. Epub 2011 Jan 7.
4
Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.随机临床试验中健康相关生活质量结局报告模式:对临床医生和生活质量研究人员的启示。
Qual Life Res. 2011 Jun;20(5):653-64. doi: 10.1007/s11136-010-9793-3. Epub 2010 Nov 26.
5
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.CONSORT 2010 声明:平行组随机试验报告的更新指南。
Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.
6
Guidance for developers of health research reporting guidelines.健康研究报告规范开发者指南。
PLoS Med. 2010 Feb 16;7(2):e1000217. doi: 10.1371/journal.pmed.1000217.
7
The quality of quality of life publications in the spinal literature: are we getting any better?脊柱文献中生活质量出版物的质量:我们是否有所进步?
J Neurosurg Spine. 2009 Nov;11(5):512-7. doi: 10.3171/2009.4.SPINE08599.
8
The importance of determining quality of life in clinical trials.在临床试验中确定生活质量的重要性。
Surgery. 2009 Jun;145(6):622-6. doi: 10.1016/j.surg.2008.11.012. Epub 2009 Apr 16.
9
A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.晚期非小细胞肺癌标准化疗方案相关生活质量的系统评价
J Thorac Oncol. 2007 Dec;2(12):1091-7. doi: 10.1097/JTO.0b013e31815cff64.
10
Patient-reported outcomes in cancer: a review of recent research and policy initiatives.癌症患者报告的结局:近期研究与政策举措综述
CA Cancer J Clin. 2007 Sep-Oct;57(5):278-300. doi: 10.3322/CA.57.5.278.